Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on June 11, 2008. The filing serves to announce the company's financial results for the fiscal year ended March 31, 2008. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), but the text of that exhibit is not present in the source material.
Material Changes
No material changes versus the prior comparable period can be summarized from the provided text, as the specific financial figures required for comparison are not included in the Form 8-K body.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items within the text provided. It solely acts as a notification that the fiscal year results have been issued via a press release.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., as the request metadata incorrectly listed "Sonoma Pharmaceuticals, Inc."
- Locate and review Exhibit 99.1 (the press release dated June 11, 2008) to obtain actual revenue, net income, and cash flow figures.
- Confirm the fiscal year end date is March 31, 2008 for accurate period comparison.
- Check for any subsequent filings that may provide updated liquidity or debt positions not detailed in this summary notice.